Kusajili – Centralise les essais cliniques mondiaux

Résultat de votre recherche par promoteur : Janssen-Cilag, Johnson & Johnson spol. s.r.o

Femme et Homme Max 99 ans
Janssen-Cilag, Johnson & Johnson spol. s.r.o MAJ Il y a 4 ans

A Randomized, 6-Week Double-Blind, Placebo-Controlled Study With an Optional 24-Week Open-Label Extension to Evaluate the Safety and Tolerability of Flexible Doses of Extended Release OROS® Paliperidone in the Treatment of Geriatric Subjects With Schizophrenia The primary objective of the study is to evaluate the safety and tolerability of flexible doses of Extended Release (ER) OROS® paliperidone (3 to 12 mg/day) as compared with placebo in subjects with s...

Pays Aucun
Organes Aucun
Spécialités Aucune

Essai clos aux inclusions

Plus d'informations